Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Axcella Health Inc
AXLA
Healthcare
Biotechnology
Axcella Health Inc. is a clinical-stage biotechnology company. The Company is focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with simultaneously impacting multiple biological pathways. Its pipeline includes lead...
therapeutic candidates for the treatment of Long COVID (also known as Post-COVID-19 Condition and Post-Acute Sequelae of COVID-19 (PASC)) associated fatigue, and the treatment of non-alcoholic steatohepatitis (NASH). AXA1665 is a product candidate for the reduction in risk of Overt Hepatic Encephalopathy (OHE) recurrence in adult patients with liver cirrhosis. AXA1125 is also being developed as a product candidate for the treatment of Long COVID. AXA1125 is an oral product candidate for the treatment of NASH. AXA1125 is an oral product candidate that contains six amino acids and derivatives.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (PINL:AXLA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Sep 20, 2023 1:37pm
RE:AXLA....you just might see this bleed for awhile
You are f'king genius!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 20, 2023 1:01pm
AXLA .... Gotta churn it...to earn it...to burn it ; )
Thatta Boy Mr. M...ur a smooth operator Common ...knock this beotch down
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 20, 2023 12:21pm
AXLA .... LoL down $3 or 25 %
Now at $9.10.....Geez ...I just might get my buy oda filled at $7.50 LMFAO
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 20, 2023 11:17am
AXLA ..... Sub $10 now ...as predicted in previous post ; )
How low can this go....Welcome to the game of "Spear-catching" Buy oda in at $7.50 Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 20, 2023 10:41am
AXLA....you just might see this bleed for awhile
Wortha repeat ; ) Sub $10 just around the corner The trend ain't your friend Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 19, 2023 10:33am
AXLA....you just might see this bleed for awhile
This is a perfect example how the Maggots manip and bury all the unsuspecting into high priced paper....nows the time to shake the tree and see how many apples fall off Pick ur spot......I'd be
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 19, 2023 8:02am
AXLA .... RS effective this a.m 25 : 1
Here's the math on ownership holdings a/o yesterdays close of $0.60: $0.60 x 25 = $15.00 On watch list
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 17, 2023 11:41am
AXLA..All that volume & price action was for 1 sole reason
Bury all the Retail DT'ers with high priced paper ; ) ..... and do this..... Axcella Announces Reverse Stock Split Effective September 19, 2023 2023-09-14 13:30 ET - News Release – AXLA
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 14, 2023 4:31pm
New Press Release - Axcella Announces Reverse Stock Split Effective September 19, 2023
– AXLA common stock expected to begin trading on a split-adjusted basis on September 19, 2023 – Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Sep 14, 2023 10:24am
RE:ACXLA .... In hindsight... I was exactly right
Oops....AXLA ....not ACXLA ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 14, 2023 10:17am
ACXLA .... In hindsight... I was exactly right
What a game
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Sep 13, 2023 2:26pm
RE:AXLA ..... LOve it ....sold to Am,erica
In hindsight.... I Might have left some on the table..... but now I'm looking like a a Champ I never cry over spilled stocks Just take what the market gives
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 12, 2023 1:55pm
AXLA ..... LOve it ....sold to Am,erica
Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 12, 2023 1:50pm
AXLA .....riding todays wave ????
Hell ya !!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Aug 29, 2023 1:31pm
AXLA ....all this on a patent news
and I didn't think it was Fryday....but hey ....get ready for the Dumpster fire
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment